About US
Contact us
-
Conflict threatens as FDA user-fee bills near a voteFDA user-fee legislation may be in the home stretch, but some proposals could slow it down as it nears the finish line. As Politico reports, amendments tagged onto user-fee bills promise to drag ou2012/4/26
-
GSK scrapes up 2% sales growth despite politics, genericsEurope is once again a big drag on pharma earnings. For GlaxoSmithKline ($GSK), the European ball and chain slowed drug and vaccine sales6%. Good thing U.S. revenues took a 9% leap--and emerging ma2012/4/26
-
Diovan rivals, plant woes pinch Novartis profitsNovartis ($NVS) results got squeezed by Diovan generics on one flank and a plant slowdown on the other. Diovan sales dropped15% as European generics continued to erode market share. And consumer healt2012/4/25
-
Pradaxa hits blockbuster mark, swelling Boehringer salesBoehringer Ingelheim is riding a sales surge. The German company expects "high single digit" growth in revenues for 2012 and another leap in 2013. That's after 2011 sales came in 5% higher, at €13.2 b2012/4/25
-
FDA warns 56 more docs of fake Avastin suppliesThe FDA has traced 56 more doctors and medical practices that may have bought phony versions of Avastin. As TheWall Street Journal reports, the agency notified the physicians and clinics in 13 states2012/4/24
-
China sweeps up dozens in whirlwind drug-capsule probeChinese police are all over the chromium-tainted drug capsules. They've detained 45 people, arrested 9 people and seized 77 million contaminated capsules, Reuters reports. Eighty illegal production2012/4/24
-
China shuts down 10 drug capsulemakersShut them down. That is what China's top drug regulator told state authorities to do to any manufacturer whose drug capsules are found to have unacceptable levels of chromium. Enforcement authorities2012/4/23
-
NIFDC Strategic Advisory Expert Committee and the Eighth Academic Committee establishedOn April 16, 2012, the inaugurating meeting for the Strategic Advisory Expert Committee and the Eighth Academic Committee of the National Institutes for Food and Drug Control (NIFDC) was held in Beiji2012/4/23
-
HGS snubs $2.6B buyout offer from Benlysta partner GSKHuman Genome Sciences ($HGSI) is entertaining bids after rebuffing partner GlaxoSmithKline's ($GSK) $2.59 billion buyout overture, thinking that its pipeline of antibody drugs and its Benlysta busines2012/4/20
-
Roche acne drug linked to eye problemsAn Israel-based team of researchers has found an uptick in eye ailments in teens and young adults taking the anti-acne med isotretinoin, sold by Swiss drug giant Roche ($RHHBY) under the brand name Ro2012/4/20